Alpa Laboratories Limited (NSE:ALPA)
India · Delayed Price · Currency is INR 68.11
+0.25 (0.37%)
Jun 19, 2026, 3:29 PM IST
Alpa Laboratories Market Cap
Alpa Laboratories has a market cap or net worth of 1.43 billion as of June 18, 2026. Its market cap has decreased by -31.27% in one year.
Market Cap
1.43B
Enterprise Value
79.43M
Revenue
1.06B
Ranking
n/a
PE Ratio
9.55
Stock Price
68.11
Market Cap Chart
Since August 7, 2007, Alpa Laboratories's market cap has increased from 1.15B to 1.43B, an increase of 24.29%. That is a compound annual growth rate of 1.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 1.43B | -12.33% |
| Dec 31, 2025 | 1.63B | -34.42% |
| Dec 31, 2024 | 2.49B | 14.68% |
| Dec 29, 2023 | 2.17B | 63.97% |
| Dec 30, 2022 | 1.33B | -20.65% |
| Dec 31, 2021 | 1.67B | 119.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 14.25B |
| Sigachi Industries | 8.77B |
| Bafna Pharmaceuticals | 3.79B |
| Valiant Laboratories | 3.69B |
| Nectar Lifesciences | 2.22B |
| Brooks Laboratories | 1.96B |
| Balaxi Pharmaceuticals | 1.31B |
| Par Drugs and Chemicals | 1.16B |